Cargando…

Fluorofenidone Inhibits the Proliferation of Lung Adenocarcinoma Cells

Background: Lung carcinoma is the leading cause of malignant tumor related mortality in China in recent decades, and the development of new and effective therapies for patients with advanced lung carcinoma is needed. We recently found that fluorofenidone (FD), a newly developed pyridine compound, re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deng, Zheng-hao, Meng, Jie, Tang, Juan, Hu, Gao-yun, Tao, Li-jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5556656/ https://www.ncbi.nlm.nih.gov/pubmed/28819390 http://dx.doi.org/10.7150/jca.18040

Ejemplares similares

Fluorofenidone Inhibits UUO/IRI-Induced Renal Fibrosis by Reducing Mitochondrial Damage
por: Liao, Xiaohua, et al.
Publicado: (2022)

Fluorofenidone Alleviates Renal Fibrosis by Inhibiting Necroptosis Through RIPK3/MLKL Pathway
por: Dai, Qin, et al.
Publicado: (2020)

Protective Effect of Fluorofenidone Against Acute Lung Injury Through Suppressing the MAPK/NF-κB Pathway
por: Lv, Xin, et al.
Publicado: (2021)

Fluorofenidone inhibits apoptosis of renal tubular epithelial cells in rats with renal interstitial fibrosis
por: Yang, Hui, et al.
Publicado: (2019)

Fluorofenidone inhibits UV‐A induced senescence in human dermal fibroblasts via the mammalian target of rapamycin‐dependent SIRT1 pathway
por: Lei, Dan, et al.
Publicado: (2018)

Fluorofenidone attenuates pulmonary inflammation and fibrosis via inhibiting the activation of NALP3 inflammasome and IL‐1β/IL‐1R1/MyD88/NF‐κB pathway
por: Song, Cheng, et al.
Publicado: (2016)

Effect of Fluorofenidone Against Paraquat-Induced Pulmonary Fibrosis Based on Metabolomics and Network Pharmacology
por: Jiang, Feiya, et al.
Publicado: (2021)

Metabolism and Mass Balance in Rats Following Oral Administration of the Novel Antifibrotic Drug Fluorofenidone
por: Wu, Wei, et al.
Publicado: (2022)

Fluorofenidone alleviates liver fibrosis by inhibiting hepatic stellate cell autophagy via the TGF-β1/Smad pathway: implications for liver cancer
por: Peng, Xiongqun, et al.
Publicado: (2023)

Fluorofenidone affects hepatic stellate cell activation in hepatic fibrosis by targeting the TGF-β1/Smad and MAPK signaling pathways
por: Peng, Yu, et al.
Publicado: (2019)

Monoacylglycerol Lipase Knockdown Inhibits Cell Proliferation and Metastasis in Lung Adenocarcinoma
por: Zhang, Hao, et al.
Publicado: (2020)

Spermidine-mediated poly(lactic-co-glycolic acid) nanoparticles containing fluorofenidone for the treatment of idiopathic pulmonary fibrosis
por: Tang, Jing, et al.
Publicado: (2017)

Fluorofenidone Offers Improved Renoprotection at Early Interventions during the Course of Diabetic Nephropathy in db/db Mice via Multiple Pathways
por: Xiong, Xuan, et al.
Publicado: (2014)

Knockdown of mitochondrial threonyl-tRNA synthetase 2 inhibits lung adenocarcinoma cell proliferation and induces apoptosis
por: Tian, Hui, et al.
Publicado: (2022)

Fluorofenidone attenuates paraquat-induced pulmonary fibrosis by regulating the PI3K/Akt/mTOR signaling pathway and autophagy
por: Jiang, Feiya, et al.
Publicado: (2021)

MMP-7 is Upregulated by COX-2 and Promotes Proliferation and Invasion of Lung Adenocarcinoma Cells
por: Zhang, J., et al.
Publicado: (2014)

CDCA2 promotes lung adenocarcinoma cell proliferation and predicts poor survival in lung adenocarcinoma patients
por: Shi, Run, et al.
Publicado: (2017)

MicroRNA-135a Inhibits Cell Proliferation by Targeting Bmi1 in Pancreatic Ductal Adenocarcinoma
por: Dang, Zheng, et al.
Publicado: (2014)

XAV939 inhibits the proliferation and migration of lung adenocarcinoma A549 cells through the WNT pathway
por: Li, Chong, et al.
Publicado: (2018)

Monoamine Oxidase A Inhibits Lung Adenocarcinoma Cell Proliferation by Abrogating Aerobic Glycolysis
por: Huang, Yumin, et al.
Publicado: (2021)

The downregulation of fibrinogen-like protein 1 inhibits the proliferation of lung adenocarcinoma via regulating MYC-target genes
por: Tang, Xi-Yang, et al.
Publicado: (2022)

KLF15 promotes the proliferation and metastasis of lung adenocarcinoma cells and has potential as a cancer prognostic marker
por: Gao, Lihua, et al.
Publicado: (2017)

miR-1290 promotes lung adenocarcinoma cell proliferation and invasion by targeting SOCS4
por: Xiao, Xuelian, et al.
Publicado: (2018)

Eriocitrin inhibits epithelial-mesenchymal transformation (EMT) in lung adenocarcinoma cells via triggering ferroptosis
por: Gao, Minglang, et al.
Publicado: (2023)

Linc00152 promotes Cancer Cell Proliferation and Invasion and Predicts Poor Prognosis in Lung adenocarcinoma
por: Zhang, Pei-pei, et al.
Publicado: (2017)

The impact of PRDX4 and the EGFR mutation status on cellular proliferation in lung adenocarcinoma
por: Mizutani, Kenichi, et al.
Publicado: (2019)

ADFP promotes cell proliferation in lung adenocarcinoma via Akt phosphorylation
por: Meng, Xia, et al.
Publicado: (2020)

The roles of CPSF6 in proliferation, apoptosis and tumorigenicity of lung adenocarcinoma
por: Zu, Yukun, et al.
Publicado: (2022)

Down-Regulation of AHNAK2 Inhibits Cell Proliferation, Migration and Invasion Through Inactivating the MAPK Pathway in Lung Adenocarcinoma
por: Wang, Dong-Wei, et al.
Publicado: (2020)

CCT8 promotes cell migration and tumor metastasis in lung adenocarcinomas
por: Wu, Zhiqiang, et al.
Publicado: (2023)

Mechanisms Behind the Inhibition of Lung Adenocarcinoma Cell by Shikonin
por: Lan, Wenjing, et al.
Publicado: (2014)

Knockdown of CENPF inhibits the progression of lung adenocarcinoma mediated by ERβ2/5 pathway
por: Hexiao, Tang, et al.
Publicado: (2021)

OSI-027 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic effect of gemcitabine both in vitro and in vivo
por: Zhi, Xiao, et al.
Publicado: (2015)

Combining a CDK4/6 Inhibitor With Pemetrexed Inhibits Cell Proliferation and Metastasis in Human Lung Adenocarcinoma
por: Ke, Yuan, et al.
Publicado: (2022)

CircRNA6783 Inhibits Cell Proliferation and Promotes Apoptosis in Lung Adenocarcinoma
por: Mu, Yinyu, et al.
Publicado: (2022)

Tsoong induces apoptosis and inhibits proliferation, migration and invasion of pancreatic ductal adenocarcinoma cells
por: Luan, Yun-Peng, et al.
Publicado: (2018)

Molecular targeting of cell-permeable peptide inhibits pancreatic ductal adenocarcinoma cell proliferation
por: Sato, Shoki, et al.
Publicado: (2017)

SERINC2-knockdown inhibits proliferation, migration and invasion in lung adenocarcinoma
por: Zeng, Yuan, et al.
Publicado: (2018)

BPTF promotes tumor growth and predicts poor prognosis in lung adenocarcinomas
por: Dai, Meng, et al.
Publicado: (2015)

FKBP51 decreases cell proliferation and increases progestin sensitivity of human endometrial adenocarcinomas by inhibiting Akt
por: Dong, Jing, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vq2hhfqjnn5vardhdkjrdgpqn8